Virginia could become the first state in the nation to restrict a new class of generic medications. But drug companies want limits and some pharmacists are concerned.
Amgen is the world’s largest biotech company – a California firm that makes medicines from living cells. These remedies, known as biologicals, are expensive and protected by patents, but the Affordable Care Act clears the way for cheaper, generic forms of these products.
Governor McDonnell took part in a news conference this week – welcoming representatives of the pharmaceutical industry to Richmond, and singing the praises of clinical trials in the Commonwealth. That might seem like a noble thing, but it could also have been part of a push to improve the industry’s image as it protects future profits through new state laws.